Friday, June 14, 2019 3:57:03 PM
06/14/19 15:39:56 3.03 3.02 3.03 5,200
06/14/19 15:09:53 3.021 3.00 3.03 5,200
06/14/19 13:07:05 3.14 3.14 3.15 6,200
06/14/19 11:18:48 3.1675 3.16 3.18 5,000
06/13/19 13:54:34 3.29 3.26 3.29 5,000
06/13/19 09:38:51 3.2217 3.21 3.23 5,000
06/12/19 15:58:08 3.22 3.24 3.26 8,900
06/12/19 14:43:12 3.34 3.34 3.35 9,600
06/12/19 13:44:13 3.29 3.25 3.27 7,400
06/12/19 12:03:24 3.2886 3.28 3.29 6,500
06/12/19 10:41:49 3.21 3.20 3.22 5,200
06/12/19 10:30:17 3.22 3.20 3.22 6,600
06/12/19 09:43:49 3.1511 3.15 3.18 5,000
06/12/19 09:43:04 3.175 3.15 3.18 5,000
06/11/19 11:58:35 3.10 3.10 3.12 7,000
06/11/19 09:45:45 3.05 3.04 3.05 6,300
06/11/19 09:45:45 3.05 3.04 3.05 7,900
06/11/19 09:45:44 3.05 3.04 3.05 6,000
06/10/19 14:20:57 3.01 3.00 3.02 18,000
06/07/19 12:12:41 2.9538 2.95 2.97 7,000
06/06/19 09:30:00 2.98 2.98 2.98 8,600
06/05/19 15:59:40 2.90 2.89 2.91 5,627
06/05/19 10:31:50 2.87 2.87 2.89 7,000
06/04/19 09:40:54 2.9301 2.93 3.03 7,400
06/03/19 15:59:15 2.91 2.87 2.89 15,399
06/03/19 15:12:13 2.90 2.90 2.92 5,200
06/03/19 11:03:19 2.93 2.91 2.93 7,000
06/03/19 09:30:00 2.86 2.83 3.10 7,800
05/31/19 15:32:11 2.8547 2.85 2.87 5,000
05/31/19 13:42:23 2.8632 2.85 2.87 6,000
05/31/19 12:42:24 2.8602 2.86 2.88 5,000
05/31/19 12:38:23 2.898 2.89 2.90 7,300
05/31/19 12:06:38 2.9169 2.90 2.92 8,000
05/31/19 11:56:49 2.92 2.92 2.94 6,000
05/31/19 10:13:59 2.96 2.95 2.96 5,700
05/31/19 10:13:59 2.96 2.95 2.96 8,700
05/31/19 09:30:00 2.97 2.92 3.05 6,400
05/31/19 09:30:00 3.02 2.92 3.05 6,485
05/30/19 14:40:15 2.97 2.98 2.99 6,100
05/30/19 11:51:38 3.0295 3.03 3.04 6,200
05/30/19 11:12:12 3.02 3.02 3.04 12,900
05/30/19 10:49:02 2.97 2.98 3.00 5,600
05/30/19 10:47:23 2.9906 2.98 3.00 5,000
05/30/19 09:34:50 3.0899 3.07 3.09 5,000
05/29/19 15:56:48 3.0678 3.05 3.07 5,000
05/29/19 15:31:22 3.003 3.00 3.01 5,400
05/29/19 15:05:37 3.02 3.08 3.09 20,800
05/29/19 12:36:48 3.12 3.12 3.13 7,200
05/29/19 11:57:30 3.15 3.15 3.16 5,100
05/29/19 10:01:36 3.20 3.17 3.20 7,300
05/29/19 09:30:00 3.16 3.16 3.17 9,100
05/29/19 09:30:00 3.22 3.16 3.17 9,177
05/28/19 12:54:05 3.191 3.18 3.20 5,900
05/28/19 11:49:43 3.2321 3.23 3.24 5,000
05/28/19 11:16:20 3.2732 3.25 3.28 5,100
05/28/19 09:59:25 3.31 3.31 3.34 5,000
05/24/19 15:15:16 3.2653 3.24 3.27 5,000
05/24/19 14:46:48 3.29 0.00 0.00 7,444
05/24/19 14:46:36 3.29 0.00 0.00 7,444
05/24/19 14:46:24 3.345 0.00 0.00 7,444
05/24/19 14:46:12 3.34 0.00 0.00 7,444
05/24/19 14:32:40 3.32 3.31 3.33 5,000
05/24/19 11:27:39 3.3722 3.37 3.39 9,800
05/24/19 10:57:37 3.4802 3.48 3.50 7,300
05/24/19 09:30:00 3.62 3.30 3.96 5,500
05/23/19 12:46:29 3.4099 3.39 3.41 8,600
05/23/19 12:36:57 3.34 3.33 3.35 5,000
05/23/19 12:34:05 3.35 3.35 3.36 8,000
05/23/19 12:25:24 3.39 3.37 3.40 5,000
05/23/19 11:53:48 3.54 0.00 0.00 6,010
05/23/19 11:53:36 3.5264 0.00 0.00 6,010
05/23/19 11:53:24 3.5501 0.00 0.00 6,010
05/23/19 11:53:12 3.5501 0.00 0.00 6,010
05/23/19 11:49:48 3.58 0.00 0.00 14,176
05/23/19 11:49:36 3.58 0.00 0.00 14,176
05/23/19 11:49:24 3.62 0.00 0.00 14,176
05/23/19 11:49:12 3.62 0.00 0.00 14,176
05/23/19 11:15:48 3.665 0.00 0.00 15,106
05/23/19 11:15:36 3.63 0.00 0.00 15,106
05/23/19 11:15:24 3.725 0.00 0.00 15,106
05/23/19 11:15:12 3.725 0.00 0.00 15,106
05/23/19 11:11:48 3.70 0.00 0.00 7,665
05/23/19 11:11:36 3.70 0.00 0.00 7,665
05/23/19 11:11:24 3.77 0.00 0.00 7,665
05/23/19 11:11:12 3.77 0.00 0.00 7,665
05/23/19 10:35:48 3.7702 0.00 0.00 8,825
05/23/19 10:35:36 3.77 0.00 0.00 8,825
05/23/19 10:35:24 3.83 0.00 0.00 8,825
05/23/19 10:35:12 3.83 0.00 0.00 8,825
05/23/19 10:34:48 3.83 0.00 0.00 16,046
05/23/19 10:34:36 3.83 0.00 0.00 16,046
05/23/19 10:34:24 3.94 0.00 0.00 16,046
05/23/19 10:34:12 3.8633 0.00 0.00 16,046
05/23/19 10:33:48 3.8859 0.00 0.00 10,311
05/23/19 10:33:36 3.84 0.00 0.00 10,311
05/23/19 10:33:24 3.89 0.00 0.00 10,311
05/23/19 10:33:12 3.84 0.00 0.00 10,311
05/23/19 10:31:48 3.849 0.00 0.00 5,125
05/23/19 10:31:36 3.819 0.00 0.00 5,125
05/23/19 10:31:24 3.85 0.00 0.00 5,125
05/23/19 10:31:12 3.819 0.00 0.00 5,125
05/23/19 10:20:48 3.82 0.00 0.00 5,219
05/23/19 10:20:36 3.78 0.00 0.00 5,219
05/23/19 10:20:24 3.84 0.00 0.00 5,219
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM

